Introduction
Biobanking is a critical component to realizing the promises of translational research and personalized medicine. The proper collection, processing, storage, and tracking of human biological samples allows researchers to better link molecular and clinical information, which in theory, allows for the development of more targeted therapies for patients. Realizing the scientific potential of well-annotated, properly preserved sample collections has led to the proliferation of large-scale biobanks by biopharmaceutical companies, academic organizations, governments, and non-profit research organizations. To this point, conservative industry projections estimate that in the United States, there are at least 300 million tissue samples in biobanks with an estimated accrual rate of 20 million samples annually. [1] As the size of sample inventories continue to grow exponentially, and economic drivers associated with biobanking (e.g., facility costs, technology investments, human capital, etc.) come to the forefront, sample management has become not only a science, but also a thriving business. First-year start-up costs for a biobank with 50,000 samples would likely cost between $3-5 million, not including information systems. Ten-year operating costs could be more than $10 million. [3] Ten years ago, the National Cancer Institute (NCI) conservatively estimated that it was spending in excess of $50 million per year on its basic biospecimen resource infrastructure. [2] It is safe to assume that this figure has increased substantially over the last decade.
Because a sizeable financial investment is required to build and operate a world-class biorepository, it is essential for organizations to have a business continuity plan in place for unforeseen events such as equipment failure, power loss, faulty technology, and natural disasters. Failure to adequately prepare for such events can render samples useless and destroy years of research. The recent freezer failure at Harvard's Brain Bank, where one-third of the world's largest collection of autistic brain samples were severely damaged, is only one example of the importance of minimizing risks in biobanking operations. [4] Fortunately, with a degree of preparation and the implementation of a business continuity plan, organizations can greatly decrease the impact an unexpected disaster could have on its biobanking operations.
Business Continuity and Disaster Recovery
Recent environmental catastrophes, such as Hurricane Sandy, which devastated large parts of the northeast United States, have highlighted the need for research institutions to have business continuity and disaster recovery plans for their biobanking operations.
Most biobanks depend heavily on technology and automated systems, and their disruption for even a few hours could cause severe financial and scientific loss by threatening the integrity of stored sample collections. The continued operations of a biobank depend on the organization's awareness of potential disasters, their ability to develop a business continuity plan to minimize disruptions of critical functions, and the capability of recovery operations to act expediently and successfully.
A business continuity plan is a comprehensive statement of consistent actions to be taken before, during, and after an unexpected event or natural disaster. As part of a biobank's standard operating procedures (SOPs), the plan should be documented and tested to ensure the continuity of operations and availability of critical resources in the event of a disaster. The primary objective of business continuity planning is to protect the organization's assets in the event that all or parts of its operations are rendered unusable. For biobanks, this includes planning for:
• Electrical outages that can compromise the use of storage freezers and other equipment
• Lags in computer systems that house valuable clinical and genomic information on each sample
• Malfunctions in tracking software that indicate the location of stored samples, as well as samples in transit
• Destroyed or inaccessible facilities due to natural disasters
The planning process should minimize the dis ruption of operations and ensure a level of organizational stability, and an orderly recovery after a disaster. Additional reasons to develop a comprehensive business continuity plan include:
• Minimizing potential financial and scientific loss It is essential that the plan be thoroughly tested and evaluated on a regular basis (once a year, at a minimum). Procedures to test the plan should be documented, as these practice drills will provide an organization with the assurance that all necessary steps are included in the plan.
Case Study: Preparedness in the Wake of a Natural Disaster
In the aftermath of "Superstorm" Sandy, an October 2012 hurricane, hundreds of thousands of refrigerated and frozen biological samples (decades of research) were at risk of being lost or destroyed due to electrical power outages in New York City and the surrounding area.
Upon learning of the power outages, BioStorage Technologies (Indianapolis, Indiana), a leading provider of sample management services, proactively dispatched its disaster recovery teams to the area. Their operational resources included a one-of-its-kind mobile biorepository vehicle outfitted with freezers and refrigerators, scalable storage facilities, and a capable staff with experience in disaster recovery. As one of the few companies with these operational resources, BioStorage Technologies' global biorepository provided an ideal solution for managing this situation. The high-tech mobile biorepository is capable of transporting thousands of samples with temperature storage requirements ranging from liquid nitrogen to ambient temperature. Relofleet® has successfully supported planned relocations of biologic samples and became the perfect solution for a rescue of samples in a natural disaster, such as Hurricane Sandy.
BioStorage Technologies partnered with Manhattanbased Alliance BioProcessing Solutions business partner, Rutgers University Cell and DNA Repository (RUCDR) Infinite Biologics, which itself was weathering the storm successfully, to support other research organizations who needed assistance in their recovery efforts. At the time, three medical centers in Manhattan, New York University (NYU) Hospital, Bellevue Hospital, and the Veterans Affairs (VA) Hospital-all partners of RUCDR-were evacuating their facilities as water poured into the lower floors within these facilities and power failed.
Dr. Andrew Brooks, chief operating officer, RUCDR, recounts the challenges posed during the recovery efforts. "We had to climb 18 stories in a high-rise that had no power, with no lights, and move tens of thousands of samples and freezer contents," said Brooks. "The samples had been kept cold, after they lost power, by the investigators who had been climbing the stairs for a couple days putting dry ice in the freezers. We were carrying these precious research samples, including infectious biomaterials and cell lines that are irreplaceable, down 18 stories of this Manhattan high-rise."
With the help of the BioStorage Technologies operations team, RUCDR staff, and 100 volunteers, the samples were cataloged, loaded into dry ice "bunker" carts, and moved to the Relofleet vehicle for transport to the RUCDR Infinite Biologics inland facility and BioStorage Technologies' headquarters.
After nearly three days of around-the-clock work, the recovery teams succeeded in rescuing the most critical samples from all three hospitals. In total, the BioStorage Technologies recovery team, along with the Relofleet vehicle, made three round-trips from Indianapolis to New York City, including extra stops in various cities for additional freezers and supplies. "It was an incredible effort, and Relofleet has made numerous trips back in order to repatriate those samples to the scientists," said Greg Swanberg, CEO, BioStorage Technologies. "Part of our mission is to be an enabler for science -we're fulfilling our mission here. These scientists aren't doing this research for financial gain -they're doing it as a life calling to better science and help patients."
Conclusion
Disasters, weather-related or not, can strike anyplace, anytime; often with little or no warning. As such, disaster recovery and business continuity planning involves more than off-site storage or backup systems. Organizations should also develop written, comprehensive disaster recovery plans that address all the critical contingency operations and functions of the biobank. The plan should include documented and tested procedures, which, if followed, will ensure the ongoing availability of critical research samples and the continuity of operations.
The probability of a disaster occurring in an organization is highly uncertain. A business continuity plan, however, is similar to liability insurance: it provides a certain level of comfort in knowing that if a major catastrophe occurs, it will not result in financial disaster.
